Superworth

Axogen price to free cash flow AXGN

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 2, 2026
135×
Peer median
29.2×

Axogen's price to free cash flow is 135× as of Nov 2, 2026.

The median for 5 medical device stocks of a similar size is 29.2×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far135×134×487×
2025453×129×491×

Against its peers

Companies in Medical - Devices nearest Axogen's size, closest first, today.

CompanyPrice to free cash flow
AXGNAxogen135×
TMDXTransMedics29.2×
ITGRInteger52.6×
LIVNLivaNova29.8×
CNMDCONMED10.5×
ZBHZimmer Biomet12.2×
Peer median29.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Axogen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.